WuXi Online Forum II on COVID-19: Harnessing Our Collective Power

7AM - 9AM PDT | 10AM - 12PM EDT | 4PM - 6PM CET | 10PM - 12AM Beijing Time

Thursday, April 16 | Live Global Webcast

At the COVID-19 pandemic spreads around the world, our industry has come together to wage a fierce battle against it. We have witnessed record speed and unprecedented collaborations on all fronts. Thank you for the efforts you have undertaken and those you will pursue in the months to come.

On April 16, we will extend the conversation in a second forum – “Harnessing Our Collective Power” - reflecting on progress to-date, lessons learned, and critical paths ahead as we combine our strengths to help the world out of this global health crisis. Led by science. Driven by dedication.

AGENDA in EDT Time Zone

10:00 – 10:04am
Welcome
Hui Cai, Vice President and Head of Content, WuXi AppTec

10:04 – 10:05am
Remembering the Lives Lost to COVID-19

10:05 – 10:25am
COVID-19: A Defining Moment
Jim Greenwood, CEO, Biotechnology Innovation Organization (BIO)
Moderated by Edward Hu, Co-CEO, WuXi AppTec

10:25 – 10:45am
Diagnosis: Lessons from the Battlefield
William Morice, President, Mayo Clinic Laboratories
Moderated by Carolyn Magill, CEO, Aetion

10:45 – 11:35am
Development in Time of Crisis
Johan Van Hoof, Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&D and Managing Director, Janssen Vaccines & Prevention, B.V.
Phil Pang, Chief Medical Officer, Vir Biotechnology
John Maraganore, CEO, Alnylam Pharmaceuticals
Chad Robins, CEO & Co-Founder, Adaptive Biotechnologies
Moderated by Steve Yang, EVP and CBO, WuXi AppTec

11:35 – 11:55am
The Future of Epidemic Readiness
Arnaud Bernaert, Head of Shaping the Future of Health and Healthcare, World Economic Forum
Moderated by Steve Usdin, Senior Editor and Head of Policy, BioCentury

11:55 – 12:05pm
Closing
Steve Bates, CEO, UK BioIndustry Association

This online Forum is brought to you by WuXi AppTec, WuXi Biologics, Morgan Stanley, Goldman Sachs, Huatai Securities, China Renaissance, UBS, Qiming Venture Partners, Frost & Sullivan, J&J Innovation, Deloitte, Zoom, Biocentury, AliHealth and Sina Medicine.